Provision of Fertility Preservation Service for service users who are at high risk of infertility and cannot store mature eggs or sperm.

Descriptions

This market engagement exercise is to inform commissioners about the market for Fertility Preservation Services for service users who are at high risk of infertility and cannot store mature eggs or sperm. NHS England is developing draft service specifications for ovarian and testicular Fertility Preservation Services for service users who are at high risk of reproductive and endocrine failure and cannot store mature eggs or sperm. The draft service specifications cover the collection, processing, testing and storage of ovarian and testicular tissue and endocrine restoration using cryopreserved ovarian tissue. NHS England would like to identify providers who are interested in delivering the ovarian and testicular Fertility Preservation Service, or part of it. The Fertility Preservation Service will be delivered as a Hub and Spoke Model. The Hub Service will need to have Onco-fertility Expertise and be able to offer comprehensive advice on fertility preservation options for service users and coordinate the provision of fertility preservation treatment through a Hub and Spoke network. Where reproductive tissue storage is the optimal treatment option, the Hub will coordinate with the service user's local hospital (Spoke sites) the surgery required for tissue collection and for storage of the tissue at a designated Tissue Establishment licenced by the Human Tissue Authority. It is estimated that there will be about 1500 fertility consultations a year which would result in reproductive tissue storage for approximately 750 service users in England each year. Interested parties should indicate whether they are interested in providing all or part of the Fertility Preservation Service. The anticipated contract period is 3 years. This notice is to advise prospective providers in the market of the commissioner's intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach. The questionnaire is available through the Atamis portal: https://health-family.force.com/s/Welcome The reference is C139903 and the closing date for submission of the completed questionnaire will be: 12pm, midday on Tuesday 7th March 2023.